Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
06/2010
06/30/2010EP1368323B1 Pyrimidine matrix metalloproteinase inhibitors
06/30/2010CN101765598A Fungicide N-5-membered fused heteroaryl-methylene-N-cycloalkyl-carboxamide derivatives
06/30/2010CN101765589A fungicide n-cycloalkyl-n-bicyclic-carboxamide derivatives
06/30/2010CN101759814A Single or double functional group thioxanthone and photoinitiator containing same
06/30/2010CN101759652A Method for synthesizing spirocyclic compound
06/29/2010US7745638 Anticancer agents; such as 4-acetylamino-1H-pyrazole-3-carboxylic acid (4-fluoro-phenyl)-amide
06/29/2010US7745637 Peptide deformylase inhibitors
06/29/2010US7745465 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease
06/29/2010US7745462 5-[R-2-(1S,2S-2-Cyclohexylcyclopentylamino)-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one, useful for treating conditions that are prevented or alleviated by activation of the adrenergic recptors
06/29/2010US7745460 LFA1 related immune and/or inflammatory disorders; interactions with leukointegrins; such as fused nitrogen heterocyclic secondary amine derivatives
06/29/2010US7745456 2,5-bis{[alkyl(or aryl)imino]aminophenyl}furans and thiophenes; "reversed" amidines; DNA-binding affinities; microbiocide; mycobacterial, fungal, protozoal infection; Mycobacterium tuberculosis, Trypanosoma spp., Candida albicans, Aspergillus spp., Cryptosporidium parvum, Giardia lamblia, Plasmodium spp.
06/29/2010US7745453 Hydroxypyrimidinone derivatives having inhibitory activity against HIV integrase
06/29/2010US7745442 Methods of reducing risk of infection from pathogens
06/29/2010US7745441 Urokinase inhibitors
06/29/2010CA2345985C Substituted 1,3-diaryl-2-pyrid-2-yl-3-(pyrid-2-ylamino)propanol derivatives,processes for their preparation, pharmaceuticals comprising these compounds and their use
06/24/2010WO2010071837A1 Pyrazine derivatives useful as inhibitors of atr kinase
06/24/2010WO2010069879A1 Pyrrole derivatives for use as plant growth regulators
06/24/2010WO2010069877A1 Isothiazole and pyrazole derivatives for use as plant growth regulators
06/24/2010WO2010069833A1 Pyrimidin- 2 -ylamino derivatives and their use to treat inflammation
06/24/2010WO2010069266A1 Heterocyclic nitrogenous or oxygenous compounds with insecticidal activity formed from dialdehydes and their preparation and uses thereof
06/24/2010WO2009106470A3 Angiotensin ii receptor antagonists
06/24/2010US20100160407 Therapeutic substituted cyclic lactams
06/24/2010US20100160343 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4
06/24/2010US20100160341 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4
06/24/2010US20100160337 Sulfamides as trpm8 modulators
06/24/2010US20100160328 New compounds useful for dpp-iv enzyme inhibition
06/24/2010US20100160293 Solid Ophthalmic Drug for External Use
06/24/2010US20100160289 Sulfonamides as trpm8 modulators
06/24/2010US20100160271 Bicyclic modulators of h1 receptors
06/24/2010DE102008062863A1 Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung Substituted (thiophenyl-carbonyl) imidazolidinones and their use
06/24/2010CA2747252A1 Pyrazine derivatives useful as inhibitors of atr kinase
06/24/2010CA2745297A1 Pyrimidin-2-ylamino derivatives and their use to treat inflammation
06/23/2010EP2198867A1 Pyrimidine-based compounds useful as GSK-3 inhibitors
06/23/2010EP2197874A1 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use
06/23/2010EP2197849A1 N- ( pyrazole- 3 -yl) -benzamide derivatives as glucokinase activators
06/23/2010EP2197551A1 Soluble guanylate cyclase activators
06/23/2010EP1511734B1 Compounds, compositions, and methods
06/23/2010CN1909907B Quinoline derivatives and use thereof for preparing mycobacterial inhibitors
06/23/2010CN1906173B Protein modifier production inhibitor
06/23/2010CN1906155B Novel hydroxamic acid ester derivant and pharmaceutical use thereof
06/23/2010CN1688194B 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
06/23/2010CN101754967A benzimidazole poly(adp-ribose)polymerase inhibitors
06/23/2010CN101754964A dna pk inhibitors
06/23/2010CN101754963A spirocyclopropyl piperidine derivatives
06/23/2010CN101754947A Process for preparation of sulfamide derivatives
06/23/2010CN101747329A 4-arylthioquinazoline derivatives and preparation methods and pharmaceutical uses thereof
06/22/2010US7741493 4,5-diphenyl-2-amino-4,5-dihydro-imidazole derivatives; antiinflammatory agent, neurodegenerative diseases; inflammatory bowel disease, rheumatoid arthritis and diseases associated with central nervous system, such as Alzheimer's disease
06/22/2010US7741485 3-[4-Chloro-2-fluoro-5-{[isopropyl(methyl)amino]carbonylaminosulfonyl}phenyl]-1-methyl-2,4-dioxo-6-trifluoromethyl-1,2,3,4-tetrahydropyrimidine; crop protection agent
06/22/2010US7741359 Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs
06/22/2010US7741341 Benzimidazole-derivatives as factor Xa inhibitors
06/22/2010US7741336 N-(1-Methyl-1-phenyl-ethyl)-3-{[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-5-trifluoromethyl-pyrimidin-4-ylamino]-methyl}-benzenesulfonamide, useful in the treatment of breast cancer
06/22/2010US7741332 Brain and nervous system disorders such as mood disorders or urinary incontinence, pain, anxiety, hearing loss; 2-(carbonylamino)-1,1-dioxo-1H-benzo[1,2,4]thiadiazines, 4-(oxo or thiooxo)-3-(carbonylamino)-quinazolines, and 1-(oxo or thiooxo)-2-(carbonylamino)-1,2-dihydroisoquinolines
06/22/2010US7741329 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia
06/22/2010US7741328 Treating inflammatory diseases such as rheumatoid arthritis, multiple sclerosis or Crohn's disease; Very Late Antigen-4 (VLA-4), also called alpha 4 beta 1 integrin; N-(sulfonamido-substituted pyrimidyl, pyridyl or pyrazyl)-L-4-(N,N-dimethylcarbamyloxy)phenylalanine compounds
06/22/2010US7741316 Pharmacological uses of azetidine derivatives
06/22/2010CA2412718C Viral polymerase inhibitors
06/22/2010CA2315715C Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
06/17/2010WO2010068806A1 Amide derivatives as btk inhibitors in the treatment of allergic, autoimmune and inflammatory disorders as well as cancer
06/17/2010WO2010068720A2 Podophyllotoxin inhibitors of topoisomerase ii
06/17/2010WO2010068663A1 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2
06/17/2010WO2010068242A1 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
06/17/2010WO2010066756A1 Polymorph ii of an antifungal compound
06/17/2010WO2010048207A3 Aryl gpr120 receptor agonists and uses thereof
06/17/2010WO2010025295A3 Compounds that modulate intracellular calcium
06/17/2010US20100152245 Insecticidal n-substituted (6-halooalkylpyridin-3-yl)-alkyl sulfoximines
06/17/2010US20100152219 Pyrazole derivatives as inhibitors of receptor tyrosine kinases
06/17/2010US20100152190 Substituted Pyrrolidine-2-Carboxamides
06/17/2010US20100152168 Substituted benzimidazolone derivatives, medicaments comprising them and their use
06/17/2010US20100152166 Compounds and methods for modulating fxr
06/17/2010US20100152155 Histone Deacetylase Inhibitors
06/17/2010CA2745969A1 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2
06/17/2010CA2744124A1 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
06/17/2010CA2742711A1 Polymorph ii of an antifungal compound
06/16/2010EP2195328A1 Certain chemical entities, compositions, and methods
06/16/2010EP2195310A1 Luminescent lanthanide (iii) chelates, chelating agents and conjugates derived thereof
06/16/2010EP1963311B1 Chromane substituted benzimidazoles and their use as acid pump inhibitors
06/16/2010EP1735302B1 4-amino-piperidine derivatives as monoamine uptake inhibitors
06/16/2010CN1867566B Aminopyrones and their use as ATM inhibitors
06/16/2010CN1829711B Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders, process for their preparation and pharmaceutical compositions containing them
06/16/2010CN1803798B Method for producing fungicide compand
06/16/2010CN1787996B Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
06/16/2010CN1764650B 2, 3, 6-trisubstituted-4-pyrimidone derivatives
06/16/2010CN101743240A ((phenyl)imidazolyl)methylheteroaryl compounds
06/16/2010CN101743237A condensed anthranilamide insecticides
06/16/2010CN101735200A Quinazoline compound
06/16/2010CN101099286B Method and installation means for installing an electrical machine
06/15/2010US7737275 simple and low cost chemical process of 2-chloro-5-[3,6-dihydro-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-4-fluoro-N-[[methyl(1-methylethyl)amino]sulfonyl]benzamide
06/15/2010US7737269 Process for preparing an alpha-lipoic acid/cyclodextrin complex and product prepared
06/15/2010US7737153 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
06/15/2010US7737152 6-carboaryl-oxy-pyrazin-2-yl-carboaryl-amines and compositions comprising said compounds
06/15/2010CA2521647C Novel hydroxamates as therapeutic agents
06/10/2010WO2010065800A1 Hydrazine substituted piperidine melanocortin receptor-specific compounds
06/10/2010WO2010065432A1 Nitrooxy derivatives as angiotensin ii receptor antagonists
06/10/2010WO2010065310A1 Inhibitors of diacylglycerol acyltransferase
06/10/2010WO2010064735A1 Quinolone compound and pharmaceutical composition
06/10/2010WO2010064707A1 2h-chromene compound and derivative thereof
06/10/2010WO2010064701A1 Pharmaceutical agent comprising quinolone compound
06/10/2010WO2010064632A1 Photo-base generator
06/10/2010WO2010064597A1 Piperidine derivative
06/10/2010WO2010032875A3 Heterocyclic carboxamide compounds